scholarly article | Q13442814 |
P50 | author | Per Ljungman | Q52717443 |
P2093 | author name string | Remberger M | |
Ringdén O | |||
Lönnqvist B | |||
Klaesson S | |||
Hägglund H | |||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | risk factor | Q1475848 |
P304 | page(s) | 4568-4572 | |
P577 | publication date | 1998-12-01 | |
P1433 | published in | Blood | Q885070 |
P1476 | title | Norethisterone treatment, a major risk-factor for veno-occlusive disease in the liver after allogeneic bone marrow transplantation | |
P478 | volume | 92 |
Q53941832 | Endocrinopathies after allogeneic and autologous transplantation of hematopoietic stem cells. |
Q35671371 | Female long-term survivors after allogeneic hematopoietic stem cell transplantation: evaluation and management |
Q35029393 | Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: Prophylaxis and treatment controversies. |
Q34479575 | Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome |
Q37783608 | Hepatic veno-occlusive disease: a chemotherapy-related toxicity in children with malignancies |
Q34099434 | Hepatic venous outflow obstruction: three similar syndromes |
Q37073000 | Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation. |
Q28083417 | Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation (EBMT) |
Q73292481 | Successful therapy of transplant-associated veno-occlusive disease with a combination of tissue plasminogen activator and defibrotide |
Q48165128 | Toxicological effects of fludarabine and treosulfan conditioning before allogeneic stem-cell transplantation |
Q58034430 | Vascular disorders of the liver |
Search more.